Application of CRISPR/Cas for Diagnosis and Management of Viral Diseases of Banana

被引:31
|
作者
Tripathi, Leena [1 ]
Ntui, Valentine Otang [1 ]
Tripathi, Jaindra Nath [1 ]
Kumar, P. Lava [2 ]
机构
[1] Int Inst Trop Agr, Nairobi, Kenya
[2] Int Inst Trop Agr, Ibadan, Nigeria
关键词
banana; viral diseases; BBTV; BSV; genome editing; CRISPR; Cas; diagnosis; disease-resistance; BUNCHY-TOP-VIRUS; INHIBIT HIV-1 REPLICATION; NUCLEIC-ACID DETECTION; GENOME; RESISTANCE; EXPRESSION; GENE; MICROPROPAGATION; CONTAINS; PROTEINS;
D O I
10.3389/fmicb.2020.609784
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Viral diseases are significant biotic constraints for banana (Musa spp.) production as they affect the yield and limit the international movement of germplasm. Among all the viruses known to infect banana, the banana bunchy top virus and banana streak viruses are widespread and economically damaging. The use of virus-resistant bananas is the most cost-effective option to minimize the negative impacts of viral-diseases on banana production. CRISPR/Cas-based genome editing is emerging as the most powerful tool for developing virus-resistant crop varieties in several crops, including the banana. The availability of a vigorous genetic transformation and regeneration system and a well-annotated whole-genome sequence of banana makes it a compelling candidate for genome editing. A robust CRISPR/Cas9-based genome editing of the banana has recently been established, which can be applied in developing disease-resistant varieties. Recently, the CRISPR system was exploited to detect target gene sequences using Cas9, Cas12, Cas13, and Cas14 enzymes, thereby unveiling the use of this technology for virus diagnosis. This article presents a synopsis of recent advancements and perspectives on the application of CRISPR/Cas-based genome editing for diagnosing and developing resistance against banana viruses and challenges in genome-editing of banana.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] A Broad Application of CRISPR Cas9 in Infectious, Inflammatory and Neurodegenerative Diseases
    Pahan, Kalipada
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (04) : 534 - 536
  • [22] A Broad Application of CRISPR Cas9 in Infectious, Inflammatory and Neurodegenerative Diseases
    Kalipada Pahan
    Journal of Neuroimmune Pharmacology, 2019, 14 : 534 - 536
  • [23] A short overview of CRISPR-Cas technology and its application in viral disease control
    Abozar Ghorbani
    Shima Hadifar
    Roya Salari
    Keramatollah Izadpanah
    Michal Burmistrz
    Alireza Afsharifar
    Mohammad Hadi Eskandari
    Ali Niazi
    Christopher E. Denes
    G. Gregory Neely
    Transgenic Research, 2021, 30 : 221 - 238
  • [24] A short overview of CRISPR-Cas technology and its application in viral disease control
    Ghorbani, Abozar
    Hadifar, Shima
    Salari, Roya
    Izadpanah, Keramatollah
    Burmistrz, Michal
    Afsharifar, Alireza
    Eskandari, Mohammad Hadi
    Niazi, Ali
    Denes, Christopher E.
    Neely, G. Gregory
    TRANSGENIC RESEARCH, 2021, 30 (03) : 221 - 238
  • [25] CRISPR-Cas System: A Brief History and Future in the Diagnosis and Treatment of Infectious Diseases
    Otlu, Baris
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2019, 1 (01): : 2 - 5
  • [26] A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System
    Anna Bellizzi
    Nicholas Ahye
    Gauthami Jalagadugula
    Hassen S. Wollebo
    Journal of Neuroimmune Pharmacology, 2019, 14 : 578 - 594
  • [27] Diverse viral cas genes antagonize CRISPR immunity
    Katz, Mark A.
    Sawyer, Edith M.
    Oriolt, Luke
    Kozlova, Albina
    Williams, Madison C.
    Margolis, Shally R.
    Johnson, Matthew
    Bondy-Denomy, Joseph
    Meeske, Alexander J.
    NATURE, 2024, 634 (8034) : 677 - 683
  • [28] CRISPR-Cas for Fungal Genome Editing: A New Tool for the Management of Plant Diseases
    Munoz, Isabel Vicente
    Sarrocco, Sabrina
    Malfatti, Luca
    Baroncelli, Riccardo
    Vannacci, Giovanni
    FRONTIERS IN PLANT SCIENCE, 2019, 10
  • [29] Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
    Kolli, Nivya
    Lu, Ming
    Maiti, Panchanan
    Rossignol, Julien
    Dunbar, Gary L.
    NEUROCHEMISTRY INTERNATIONAL, 2018, 112 : 187 - 196
  • [30] A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System
    Bellizzi, Anna
    Ahye, Nicholas
    Jalagadugula, Gauthami
    Wollebo, Hassen S.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (04) : 578 - 594